Additionally, research suggests that GLP-1 agonists like semaglutide may have an anti-inflammatory effect that can further help lower the risk of heart attack or stroke in people with heart disease and obesity and/or type 2 diabetes
Then, you can throw away the pen or used needle and syringe in a sharps disposal container to prevent someone else from accidentally getting injured
Sofwave uses ultrasound technology to target the deeper layers of the skin, specifically the mid-dermis, to stimulate collagen production
A cookie today seems far more appealing than the abstract idea of avoiding diabetes in the future
And then the two new ones that everybody's talking about is Wegovywhich is the sister drug to Ozempic, an injectable GLP-1 agonist, and the most recent one to hit the airwaves in FDA approval is Zepbound, which is the sister drug to Mounjaro, and that one's a GLP and GIP medication, but also an injectable
You can read the current FDA prescribing information for Zepbound here